Literature DB >> 31970683

Dual antiplatelet therapy in coronary artery disease: from the past to the future prospective.

Antonio Mangieri1, Francesco Gallo2, Alessandro Sticchi2, Arif A Khokhar2, Alessandra Laricchia2, Francesco Giannini2, Antonio Colombo2.   

Abstract

Antiplatelet therapy, the cornerstone of post coronary stenting antithrombotic therapy, reduces the rate of hard clinical endpoints in patients treated both conservatively and invasively following an acute coronary syndrome, as well as in those patients with chronic stable coronary disease who receive a coronary stent. The development of newer antiplatelet and direct anticoagulant agents provides new options in the antithrombotic management of patients with coronary artery disease, enabling different therapeutic combinations to be tailored to an individual patient's bleeding and ischemic risk profile. In this review, we will summarize the history of dual antiplatelet therapy, discuss the latest evidence and future perspectives in treating patients with coronary artery disease.

Entities:  

Keywords:  Acute coronary syndromes; Aspirin; Bleeding; Direct oral anticoagulants; Dual antiplatelet therapy; Myocardial infarction; P2Y12 inhibitors; Stent thrombosis

Year:  2020        PMID： 31970683     DOI： 10.1007/s12928-020-00642-w

Source DB:  PubMed          Journal:  Cardiovasc Interv Ther        ISSN： 1868-4297


  6 in total

1.  Supplementation with omega-3 or omega-6 fatty acids attenuates platelet reactivity in postmenopausal women.

Authors:  Adriana Yamaguchi; Livia Stanger; John Cody Freedman; Amanda Prieur; Rachel Thav; Jennyfer Tena; Theodore R Holman; Michael Holinstat
Journal:  Clin Transl Sci       Date:  2022-07-25       Impact factor: 4.438

Review 2.  Antiplatelet Therapy for Atherothrombotic Disease in 2022-From Population to Patient-Centered Approaches.

Authors:  Georges Jourdi; Anne Godier; Marie Lordkipanidzé; Guillaume Marquis-Gravel; Pascale Gaussem
Journal:  Front Cardiovasc Med       Date:  2022-01-28

3.  Antiplatelet medications and risk of intracranial hemorrhage in patients with metastatic brain tumors.

Authors:  Eric J Miller; Rushad Patell; Erik J Uhlmann; Siyang Ren; Hannah Southard; Pavania Elavalakanar; Griffin M Weber; Donna Neuberg; Jeffrey I Zwicker
Journal:  Blood Adv       Date:  2022-03-08

4.  Relationship between platelet aggregation and stroke risk after percutaneous coronary intervention: a PENDULUM analysis.

Authors:  Yuji Matsumaru; Takanari Kitazono; Kazushige Kadota; Koichi Nakao; Yoshihisa Nakagawa; Junya Shite; Hiroyoshi Yokoi; Ken Kozuma; Kengo Tanabe; Takashi Akasaka; Toshiro Shinke; Takafumi Ueno; Atsushi Hirayama; Shiro Uemura; Takeshi Kuroda; Atsushi Takita; Atsushi Harada; Raisuke Iijima; Yoshitaka Murakami; Shigeru Saito; Masato Nakamura
Journal:  Heart Vessels       Date:  2022-01-01       Impact factor: 1.814

Review 5.  Advances in the Protective Mechanism of NO, H2S, and H2 in Myocardial Ischemic Injury.

Authors:  Wei-Lu Wang; Tian-Yu Ge; Xu Chen; Yicheng Mao; Yi-Zhun Zhu
Journal:  Front Cardiovasc Med       Date:  2020-10-30

6.  Differential Impact of Clinical and Genetic Factors on High Platelet Reactivity in Patients with Coronary Artery Disease Treated with Clopidogrel and Prasugrel.

Authors:  Yuichi Saito; Takeshi Nishi; Shinichi Wakabayashi; Yuji Ohno; Hideki Kitahara; Noritaka Ariyoshi; Yoshio Kobayashi
Journal:  J Atheroscler Thromb       Date:  2021-07-08       Impact factor: 4.394
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.